SCHEMBL4368178

SCHEMBL4368178

NC(Cc1c[nH]c2ccccc12)C(=O)NCCCCCC(=O)NOCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 1/20 0.55
ACHE P22303 9/20 0.53
BCHE P06276 8/20 0.53
HDAC3 O15379 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
LMNA P02545 1/20 0.51
MPO P05164 1/20 0.51
MAPT P10636 1/20 0.51
TSHR P16473 1/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
KMT2A Q03164 1/20 0.51
HIF1A Q16665 1/20 0.51
NMBR P28336 1/20 0.51
MMP2 P08253 1/20 0.51
MMP9 P14780 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1233329 0.86 BMP1 (0.63) BMP1HDAC3HDAC1MEN1KMT2A
SCHEMBL1233735 0.86 BMP1 (0.63) BMP1HDAC3HDAC1MEN1KMT2A
SCHEMBL6013939 0.86 BMP1 (0.65) BMP1ACHEBCHEKDM4EMEN1
SCHEMBL3792994 0.86 BMP1 (0.65) BMP1ACHEBCHEKDM4EMEN1
SCHEMBL4365637 0.85 HDAC8 (0.64) ACHEBCHEHDAC3HDAC1HDAC8
SCHEMBL29894990 0.85 ACHE (0.61) ACHEBCHEHDAC3HDAC1HDAC8
Hydrochloric Acid SCHEMBL21082960 0.84 ACHE (0.65) ACHEBCHEHDAC8KDM4EMEN1
Hydrochloric Acid SCHEMBL21082959 0.84 ACHE (0.65) ACHEBCHEHDAC8KDM4EMEN1
Hydrochloric Acid SCHEMBL21082975 0.84 ACHE (0.65) ACHEBCHEHDAC8KDM4EMEN1
Hydrochloric Acid SCHEMBL21082961 0.84 ACHE (0.65) ACHEBCHEHDAC8KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569724-B2 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors TOPOTARGET UK LIMITED (GB) 2009-08-04 US disclosed
EP-2083005-A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors TopoTarget UK Limited (GB) 2009-07-29 EP disclosed
EP-1598067-A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors TopoTarget UK Limited (GB) 2005-11-23 EP disclosed
US-20040092598-A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors TOPOTARGET UK LIMITED (GB) 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092598-A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors HDAC1, HDAC11, HDAC3 BMP1 3910/4885ACHE 3831/4885BCHE 4250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.